Corvus Pharmaceuticals, Inc. Soared
Mon, Sep 20, 2021 at 05:30 PM
Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) shot up at $6.17, a gain of 16%. On Fri, Sep 17, 2021, CRVS:NASDAQ hit a New 2-Week High of $5.32. The stock got featured on our News Catalysts scanner on Sun, Sep 19, 2021 at 12:03 PM in the 'BIOTECH' category. From Fri, Sep 03, 2021, the stock recorded 44.44% Up Days and 30.00% Green Days
About Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ)
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is engaged in development and commercialization of novel immuno-oncology therapies that are designed to harness the immune system to attack cancer cells.
Top 10 Gainers:
- Edesa Biotech, Inc. (EDSA:NASDAQ), 102.72%
- BLNG (BLNG:NASDAQ), 100%
- ARQQ (ARQQ:NASDAQ), 36.58%
- SNTG (SNTG:NASDAQ), 28.8%
- BROS (BROS:NYSE), 18.39%
- DRMA (DRMA:NASDAQ), 16.79%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 15.98%
- UCL (UCL:NASDAQ), 14.1%
- Synlogic, Inc. (SYBX:NASDAQ), 12.77%
- SRNG (SRNG:NASDAQ), 12.73%